Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

State of the field: cellular and exosomal therapeutic approaches in vascular regeneration

Tracy EP., Stielberg V., Rowe G., Benson D., Nunes SS., Hoying JB.

Narrative Review on Face & Skin, published in Am J Physiol Heart Circ Physiol (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Am J Physiol Heart Circ Physiol (2022)
Reported sample size
—
Source database
Europe PMC
PMID
35179976
PMCID
PMC8957327
DOI
10.1152/ajpheart.00674.2021
Citations
18

Abstract (original English)

Pathologies of the vasculature including the microvasculature are often complex in nature, leading to loss of physiological homeostatic regulation of patency and adequate perfusion to match tissue metabolic demands. Microvascular dysfunction is a key underlying element in the majority of pathologies of failing organs and tissues. Contributing pathological factors to this dysfunction include oxidative stress, mitochondrial dysfunction, endoplasmic reticular (ER) stress, endothelial dysfunction, loss of angiogenic potential and vascular density, and greater senescence and apoptosis. In many clinical settings, current pharmacologic strategies use a single or narrow targeted approach to address symptoms of pathology rather than a comprehensive and multifaceted approach to address their root cause. To address this, efforts have been heavily focused on cellular therapies and cell-free therapies (e.g., exosomes) that can tackle the multifaceted etiology of vascular and microvascular dysfunction. In this review, we discuss 1 ) the state of the field in terms of common therapeutic cell population isolation techniques, their unique characteristics, and their advantages and disadvantages, 2 ) common molecular mechanisms of cell therapies to restore vascularization and/or vascular function, 3 ) arguments for and against allogeneic versus autologous applications of cell therapies, 4 ) emerg

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Endothelium, VascularAnimalsVascular DiseasesRegenerationOxidative StressMicrovessels

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research